Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use.

Tierney JF, Vale C, Riley R, Smith CT, Stewart L, Clarke M, Rovers M.

PLoS Med. 2015 Jul 21;12(7):e1001855. doi: 10.1371/journal.pmed.1001855. eCollection 2015 Jul.

2.

How individual participant data meta-analyses have influenced trial design, conduct, and analysis.

Tierney JF, Pignon JP, Gueffyier F, Clarke M, Askie L, Vale CL, Burdett S; Cochrane IPD Meta-analysis Methods Group.

J Clin Epidemiol. 2015 Jun 3. pii: S0895-4356(15)00268-1. doi: 10.1016/j.jclinepi.2015.05.024. [Epub ahead of print]

3.

Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.

Wei Y, Royston P, Tierney JF, Parmar MK.

Stat Med. 2015 Sep 20;34(21):2881-98. doi: 10.1002/sim.6556. Epub 2015 Jun 23.

PMID:
26099573
4.

Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.

Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF; PRISMA-IPD Development Group.

JAMA. 2015 Apr 28;313(16):1657-65. doi: 10.1001/jama.2015.3656.

PMID:
25919529
5.

Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non-Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials.

Vale CL, Burdett S, Fisher DJ, Navani N, Parmar MK, Copas AJ, Tierney JF.

Clin Lung Cancer. 2015 May;16(3):173-182.e4. doi: 10.1016/j.cllc.2014.11.007. Epub 2014 Nov 22. Review.

6.

Measuring the impact of methodological research: a framework and methods to identify evidence of impact.

Brueton VC, Vale CL, Choodari-Oskooei B, Jinks R, Tierney JF.

Trials. 2014 Nov 27;15:464. doi: 10.1186/1745-6215-15-464.

7.

Preoperative chemotherapy for non-small-cell lung cancer--authors' reply.

Burdett S, Rydzewska LH, Tierney JF, Auperin A, Pignon JP, Le Pechoux C, Le Chevalier T, van Meerbeeck J.

Lancet. 2014 Jul 19;384(9939):233. doi: 10.1016/S0140-6736(14)61209-5. No abstract available.

PMID:
25042232
8.

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data.

NSCLC Meta-analysis Collaborative Group.

Lancet. 2014 May 3;383(9928):1561-71. doi: 10.1016/S0140-6736(13)62159-5. Epub 2014 Feb 25. Review.

9.

Response to: Practical methods for incorporating summary time-to-event data into meta. Authors' reply.

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR.

Trials. 2013;14:391. Epub 2013 Nov 19. No abstract available.

10.

Strategies to improve retention in randomised trials: a Cochrane systematic review and meta-analysis.

Brueton VC, Tierney JF, Stenning S, Meredith S, Harding S, Nazareth I, Rait G.

BMJ Open. 2014 Feb 4;4(2):e003821. doi: 10.1136/bmjopen-2013-003821.

11.

Use of strategies to improve retention in primary care randomised trials: a qualitative study with in-depth interviews.

Brueton VC, Stevenson F, Vale CL, Stenning SP, Tierney JF, Harding S, Nazareth I, Meredith S, Rait G.

BMJ Open. 2014 Jan 24;4(1):e003835. doi: 10.1136/bmjopen-2013-003835.

12.

Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data.

Mauguen A, Pignon JP, Burdett S, Domerg C, Fisher D, Paulus R, Mandrekar SJ, Belani CP, Shepherd FA, Eisen T, Pang H, Collette L, Sause WT, Dahlberg SE, Crawford J, O'Brien M, Schild SE, Parmar M, Tierney JF, Le Pechoux C, Michiels S; Surrogate Lung Project Collaborative Group.

Lancet Oncol. 2013 Jun;14(7):619-26. doi: 10.1016/S1470-2045(13)70158-X. Epub 2013 May 14.

13.
14.

A closer look at the effects of postoperative radiotherapy by stage and nodal status: updated results of an individual participant data meta-analysis in non-small-cell lung cancer.

Burdett S, Rydzewska L, Tierney JF, Fisher DJ; PORT Meta-analysis Trialist Group.

Lung Cancer. 2013 Jun;80(3):350-2. doi: 10.1016/j.lungcan.2013.02.005. Epub 2013 Feb 27. No abstract available.

PMID:
23453644
15.

Re: Andrew J. Stephenson, Michel Bolla, Alberto Briganti, et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol 2012;61:443-51.

Sydes MR, Vale C, Kneebone A, Pearse M, Richaud P, Tierney JF, Parker CC.

Eur Urol. 2012 Dec;62(6):e99. doi: 10.1016/j.eururo.2012.09.003. Epub 2012 Sep 11. No abstract available.

PMID:
23018161
16.

Evaluation of patient involvement in a systematic review and meta-analysis of individual patient data in cervical cancer treatment.

Vale CL, Tierney JF, Spera N, Whelan A, Nightingale A, Hanley B.

Syst Rev. 2012 May 7;1:23. doi: 10.1186/2046-4053-1-23.

17.

Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis.

Vale CL, Tierney JF, Fisher D, Adams RA, Kaplan R, Maughan TS, Parmar MK, Meade AM.

Cancer Treat Rev. 2012 Oct;38(6):618-25. doi: 10.1016/j.ctrv.2011.11.002. Epub 2011 Nov 26. Review.

PMID:
22118887
18.

Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches for estimating the hazard ratio under a random effects model.

Bowden J, Tierney JF, Simmonds M, Copas AJ, Higgins JP.

Res Synth Methods. 2011 Sep;2(3):150-62. doi: 10.1002/jrsm.45.

PMID:
26061783
19.

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

Langley RE, Burdett S, Tierney JF, Cafferty F, Parmar MK, Venning G.

Br J Cancer. 2011 Oct 11;105(8):1107-13. doi: 10.1038/bjc.2011.289. Epub 2011 Aug 16. Review.

20.

Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.

Bowden J, Tierney JF, Copas AJ, Burdett S.

BMC Med Res Methodol. 2011 Apr 7;11:41. doi: 10.1186/1471-2288-11-41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk